KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Current Deferred Revenue (2016 - 2025)

Evolent Health (EVH) has 11 years of Current Deferred Revenue data on record, last reported at $1.9 million in Q3 2025.

  • For Q3 2025, Current Deferred Revenue fell 35.79% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $1.9 million, down 35.79%, while the annual FY2024 figure was $2.5 million, 58.05% down from the prior year.
  • Current Deferred Revenue reached $1.9 million in Q3 2025 per EVH's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $18.8 million in Q1 2021 and bottomed at $1.9 million in Q3 2025.
  • Average Current Deferred Revenue over 5 years is $8.3 million, with a median of $7.0 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 46.42% in 2021, then tumbled 59.95% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $11.9 million in 2021, then tumbled by 51.79% to $5.8 million in 2022, then grew by 3.79% to $6.0 million in 2023, then crashed by 58.05% to $2.5 million in 2024, then fell by 25.37% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $1.9 million in Q3 2025, $2.3 million in Q2 2025, and $5.0 million in Q1 2025.